Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma

Non-small cell lung cancer is still diagnosed at late stage due to the lack of early symptoms and methods of diagnostic prevention. In the past ten years several targeted therapies have been introduced or explored. Tyrosine kinase inhibitors and immunotherapy are currently considered the most effect...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Med Case Rep
Main Authors: Zarogoulidis, Paul, Huang, Haidong, Tsiouda, Theodora, Sardeli, Chrysa, Trakada, Georgia, Veletza, Lemonia, Kallianos, Anastasios, Kosmidis, Christoforos, Rapti, Aggeliki, Papaemmanouil, Liana, Hatzibougias, Dimitrios, Drougas, Dimitrios, Bai, Chong, Hohenforst-Schmidt, Wolfgang
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5671388/
https://ncbi.nlm.nih.gov/pubmed/29124007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2017.10.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados